Compare Ascendis Pharma A/S (ASND) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Cronos Group Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Cronos Group Inc trades at $3.08 (market cap $1.14B). The key difference: Ascendis Pharma A/S is far larger — about 14.6× Cronos Group Inc's market cap. Which is the better fit depends on your goals.
| ASND | CRON | |
|---|---|---|
Market Cap | $16.67B | $1.14B |
Sector | Health | Health |
52-Week High | $277.18 | $3.27 |
52-Week Low | $189.74 | $2.30 |
Enterprise Value | $17.04B | $341.13M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
